GURUFOCUS.COM » STOCK LIST » Oceania » Australia » ASX » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Short Percentage of Float
Switch to:

Vectus Biosystems (ASX:VBS) Short Percentage of Float


View and export this data going back to 2016. Start your Free Trial

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison

For the Biotechnology subindustry, Vectus Biosystems's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   
Vectus Biosystems Short Percentage of Float Distribution

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Short Percentage of Float falls in comparison to its industry or sector. The grey bar indicates the Short Percentage of Float's extreme value range as defined by GuruFocus.


Vectus Biosystems (ASX:VBS) Business Description

Vectus Biosystems logo
Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Short Percentage of Float
Comparable Companies
ASX:PAB ASX:DXB ASX:IXC ASX:ATH ASX:HXL ASX:CHM ASX:AGN ASX:AVE ASX:MEM ASX:NSB OCSE:NOVO B ASX:CSL NAS:REGN NAS:VRTX NAS:MRNA XKRX:207940 NAS:BNTX HKSE:02269 NAS:SGEN SZSE:300122
Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Website
http://www.vectusbiosystems.com.au
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines